|
2018 Update: How to Write Effective SOPs for FDA inspection
Everyday 10.00 PM
http://https://worldcomplianceseminars.com/webinardetails/415
Hollywood FL Wisconsin 33021
Report Abuse
|
|
2018 Update: How to Write Effective SOPs for FDA inspection & Regulatory Compliance
Description
Standard Operating Procedures (SOPs) are required by law for companies that are regulated by the Code of Federal Regulations such as Title 21 and Title 493. Yet there is no guidance on how to write, organize and maintain SOPs. Consequently, SOPs are frequently written in a way that makes compliance difficult or downright impossible. Worse, this often leads to many regulatory errors that first come to light during a FDA audit.
This webinar will show you how to write, organize, and maintain SOPs and train personnel in a way that will ensure compliance in a way that is concise, reproducible and easy to follow.
Why should you attend
This webinar will instruct the participant on how to write, organize, and maintain SOPs and train personnel in a way that will ensure compliance in a way that is concise, reproducible and easy to follow. It will begin with a strategic view of SOPs in a company and how SOPs can help streamline operations in addition to ensuring regulatory compliance. This will be followed by explanation on how to get from regulations to the SOP. Finally, Best Practices for creating, implementing and maintaining SOPs using a risk based approach and getting SOPs ready for inspection will be presented.
Areas Covered
• SOPs and their relation to the regulations
• SOPs as part of the company's regulatory infrastructure
• SOP on SOPs and how to ensure conciseness, consistency and ease of use
• Risk Based approach on SOP Best Practices for creation and maintenance
• Training on SOPs
• Tools for SOP tracking and when is validation required
• What the FDA looks for in SOPs during an inspection
Who will Benefit
• CEO
• Regulatory VP
• Quality VPs
• IT VPs
• Regulatory Affairs professionals
• Quality Managers
• Quality Engineers
• Small business owners
• GxP
• Consultants
Industries who can attend
This 90-minute online course is intended for professionals in the Medical Device, Biotechnology,Pharmaceutical Industry. Although not presently stated in the draft , the same guide could be used by FDA Regulated Industries personnel.
Angela Bazigos
Angela Bazigos.CEO of Touchstone Technologies Inc. She has 40 years of experience in the Life Sciences & Healthcare Industries. Experience combines Quality Assurance, Regulatory Compliance, Business Administration, Information Technology, Project Management, Clinical Lab Science, Microbiology, Food Safety, Turnarounds and Business Development. Past employers / clients include Roche, Novartis, Genentech & PriceWaterhouseCoopers. Positions include Chief Compliance Officer at Morf Media. Co-authored & prototyped 21 CFR 11 guidance with FDA. Co-authored Computerized Systems in Clinical Research w/ FDA. Patent on speeding up software compliance. Recently quoted in Wall Street Journal for using training to bring regulatory compliance to the Boardroom. National Trainer for Society of Quality Assurance. Comments / collaborates with FDA on new guidance documents. Former President of Pacific Regional Chapter of Society of Quality Assurance. Stanford’s Who’s Who for Life Sciences
|$179 One Dial-in One Attendee|$279 One Dial In - Max 10 attendees|$399 Multiple locations upto 5 dial in|$249 Available within 24 hrs after|$299 CD/DVD will be dispatched after
https://worldcomplianceseminars.com/webinardetails/415 |
conference manager Phone: 03472825400 Email: subscribe (at) worldcomplianceseminars.com |
|
Report Abuse |
|
|
|
|
|
List your Event |
| Similar Events | FL: Live Webinar New and Expected Guidances on Data Standards and Electron Live Webinar New and Expected Guidances on Data Standards and Electronic Submissions for Drugs and Medical Products
Description
Each FDA center has different guidelines and processes to follow in order to have a successful submission for the re Date Posted: 30-Apr-18
| FL: Live Webinar New and Expected Guidances on Data Standards and Electron Live Webinar New and Expected Guidances on Data Standards and Electronic Submissions for Drugs and Medical Products
Description
Each FDA center has different guidelines and processes to follow in order to have a successful submission for the re Date Posted: 11-May-18
| Brisbane CA: 2 Day Workshop: Writing & Managing Effective SOPs 2 Day Workshop: Writing & Managing Effective SOPs
Location 1: San Francisco, CA
Jul 19 - 20
Description
Perhaps if everything always executed as planned then we would not need procedures, but this is not the case in the real wor Date Posted: 21-May-18
| 94005: 2 Day Workshop: Writing & Managing Effective SOPs 2 Day Workshop: Writing & Managing Effective SOPs
Location 1: San Francisco, CA
Jul 19 - 20
Description
Every biopharmaceutical company has SOPs, and new staff members are told that the company “has to have them” and that each emplo Date Posted: 04-May-18
| Shoreline Court: 2 Day Workshop: Writing & Managing Effective SOPs 2 Day Workshop: Writing & Managing Effective SOPs
Location 1: San Francisco, CA
Jul 19 - 20
Description
Every biopharmaceutical company has SOPs, and new staff members are told that the company “has to have them” and that each employe Date Posted: 17-May-18
| DC / U.S. Capitol : 2 Days Workshop: FDA 21 CFR Part 11 Compliance – Validation Seminar 2 Days Workshop: FDA 21 CFR Part 11 Compliance – Validation Seminar 2018
Description
Spreadsheets such as Excel, are available for creating a wide range of end user applications, including widespread use in the laboratory, creating customiz Date Posted: 17-May-18
| DC / U.S. Capitol : 2 Days Workshop: FDA 21 CFR Part 11 Compliance – Validation Seminar 2 Days Workshop: FDA 21 CFR Part 11 Compliance – Validation Seminar 2018
Location 1: Washington DC
Jun 28 - 29
Description
Spreadsheets such as Excel, are available for creating a wide range of end user applications, including wides Date Posted: 04-May-18
| DC / U.S. Capitol : 2 Days Workshop: FDA 21 CFR Part 11 Compliance – Validation Seminar 2 Days Workshop: FDA 21 CFR Part 11 Compliance – Validation Seminar 2018
Location 1: Washington DC
Jun 28 - 29
Description
GxP records generated by spreadsheet calculations are electronic records and should comply with FDA’s 21 CF Date Posted: 21-May-18
| FL: Live Webinar Write effective SOPs & Work Instructions Live Webinar Write effective SOPs & Work Instructions
Description
Standard Operating Procedures – the documentation required by regulation – is essential to the effective and compliant running of any regul Date Posted: 02-May-18
| FL: Live Webinar Write effective SOPs & Work Instructions Live Webinar Write effective SOPs & Work Instructions
Description
Standard Operating Procedures – the documentation required by regulation – is essential to the effective and compliant running of any regulated business. Unfortunately, many Date Posted: 11-May-18
| FL: Conducting a life sciences documentation and training gap analysis Conducting a life sciences documentation and training gap analysis
Description
The relationship between government regulations, actual job tasks performed by workers, compliance requirements, equipment maintenance and Date Posted: 27-Apr-18
| FL: Conducting a life sciences documentation and training gap analysis Conducting a life sciences documentation and training gap analysis
Description
The relationship between government regulations, actual job tasks performed by workers, compliance requirements, equipment maintenance and operational requirements, Date Posted: 29-May-18
| FL: 3-hrs Webinar-Deciding When to Submit a 510(k) for a Change to an Exis 3-hrs Webinar-Deciding When to Submit a 510(k) for a Change to an Existing Device – FDA’s Final Guidance
Description
A premarket notification (510(k)) is required when a legally marketed device subject to 510(k) requirements is about to be Date Posted: 30-Apr-18
| FL: 3-hrs Webinar-Deciding When to Submit a 510(k) 3-hrs Webinar-Deciding When to Submit a 510(k) for a Change to an Existing Device – FDA’s Final Guidance
Description
A premarket notification (510(k)) is required when a legally marketed device subject to 510(k) requirements is about to b Date Posted: 11-May-18
| FL: 3-hrs Virtual Training 2018 Latest FDA thinking on deciding when 3-hrs Virtual Training 2018 Latest FDA thinking on deciding when to Submit a 510(k) for a Change to an Existing Device – FDA’s Final Guidance
Description
A premarket notification (510(k)) is required when a legally marketed device subject Date Posted: 31-May-18
|
|
Map locations are shown as per geocoding services and they depeneds on the accuracy of the address. If address is wrong it may show wrong map. If you put a listing which shows wrong map, please remove the listing and create a new one with correct address details.
Please note: The information on this site is submitted by users. CanadianDesi never checks accuracy of the information. Please use this information at your risk. If you have any question or concern regarding this listing, or you know that the above information is not accurate, please Contact Us. Thanks.
|
Please note: The information on this site is submitted by users. CanadianDesi never checks accuracy of the information. Please use this information at your risk. If you have any question or concern regarding this listing, or you know that the above information is not accurate, please Contact Us. Thanks.
|
|